Supreme Court to Rule on Nationwide Access to Abortion Drug

The Supreme Court has agreed to consider whether to restrict access to the abortion drug mifepristone nationwide, even in states where abortion is still legal. The case revolves around the scope of the FDA's authority to regulate the drug, which has been deemed safe and effective by the medical community. The decision could have significant implications for abortion rights and is expected to be decided by July, making it a key issue in the upcoming presidential election. The Biden administration and the drug's manufacturer are urging the court to reverse a federal appeals court decision that would restrict access to the drug, while opponents of abortion want the court to go further and declare the drug's initial approval in 2000 unlawful.